IN VITRO DIAGNOSTICS Mergers & Acquisitions HalioDx Qiagen NV Qiagen Marseille SA Management of Qiagen NV division Qiagen Marseille SA have formed a new company, HalioDx , through a buy-out
PledPharma AB ’s Phase IIb studies to reduce chemotherapy-induced side effects in colorectal cancer have given the Swedish biotech what it needs to initiate discussions with regulators to plan Phase I
IN VITRO DIAGNOSTICS Mergers & Acquisitions Roche Roche Molecular Diagnostics IQuum Inc. Roche paid $275mm up front for private molecular diagnostics company IQuum Inc. , which is also eligible
In Vitro Diagnostics Mergers & Acquisitions /In Vitro Diagnostics Alere Inc. VitaPath Genetics Inc. Diagnostics company Alere Inc. has licensed global marketing rights to VitaPath Genetics Inc.